Stage II Lung Cancer
8
2
3
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
25.0%
2 terminated out of 8 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources
Avecure Flexible Microwave Ablation Probe For Lung Nodules
Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study
Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial
Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors
Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer
Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy
Ask Questions (ASQ):Implementation of a Communication Intervention